The Effect of the Oral PKC b Inhibitor, Ruboxistaurin, on Visual Loss and Diabetic Macular Edema. In 24th Annual American society of Retinal Specialists and the 6th Annual European Vitreoretinal Society Meeting. presented at the 09/09/2006, Cannes, France. Retrieved from http://www.medscape.com/viewcollection/6085. (2006).
The Effect of Riboxistaurin (RBX) on Visual Acuity Loss Due to Diabetic Macular Edema (DME). In 15th Scientific Meeting of the Eye Complications Study Group of the European Association for the Study of Diabetes (EASDec). presented at the 27/05/2005, Coimbra, Portugal. Retrieved from http://www.easdec.org/pages/default.asp?id=2&sID=75. (2005).
The Effect of Cataract Surgery on the Development of Geographic Atrophy. In Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO). presented at the 06/05/2007, Fort Lauderdale, FL.. (2007).
Baseline Patient Characteristics in the PKC-DRS2 Trial: The Effect of The PKC-b Inhibitor Ruboxistaurin on Moderate Visual Loss. In 13th Congress of the European Society of Ophthalmology (SOE) and the 103rd Congress of German Society of Ophthalmology (DOG). presented at the 27/09/2005, Berlin, Germany. Retrieved from http://www.dog2005.org/images/soe_dog_programme_2005.pdf. (2005).
The Age-Related Eye Disease Study (AREDS) Simple Scale: The Relation of the AREDS Simple Scale for AMD to Long-Term Progression to Advanced AMD and Reduced Vision. In Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO). presented at the 06/05/2007, Fort Lauderdale, FL.. (2007).